Protein coexpression using FMDV 2A: Effect of "linker" residues

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Minskaia, Ekaterina ^a   Ryan, Martin D ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARBOXY TERMINAL SEQUENCE; FOOT AND MOUTH DISEASE VIRUS; FOOT AND MOUTH DISEASE VIRUS 2A; GENE INSERTION; MUTATION; PROTEIN EXPRESSION; RNA TRANSLATION; AMINO ACID SEQUENCE; BIOSYNTHESIS; GENE VECTOR; GENETICS; MOLECULAR CLONING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROCEDURES; TRANSPOSON; METHODOLOGY;

RECOMBINANT PROTEIN; TRANSPOSON; VIRUS PROTEIN; VIRUS PROTEIN 2A;

AMINO ACID SEQUENCE; BASE SEQUENCE; CLONING, MOLECULAR; DNA TRANSPOSABLE ELEMENTS; GENETIC VECTORS; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; VIRAL PROTEINS;

EID: 84880154492     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/291730     Document Type: Article

References (50)

1. de Felipe P., Polycistronic viral vectors. Current Gene Therapy 2002 2 3 355 378 2-s2.0-0036728609
2. Pfützner W., Retroviral bicistronic vectors. Drug News and Perspectives 2008 21 9 473 480 2-s2.0-61849097214 10.1358/dnp.2008.21.9.1290817
3. Luke G., Agbo E., Translating 2A research into practice. Innovations in Biotechnology 2012 Rijeka, Croatia InTech 161 186
4. Martínez-Salas E., Internal ribosome entry site biology and its use in expression vectors. Current Opinion in Biotechnology 1999 10 5 458 464 2-s2.0-0344898562 10.1016/S0958-1669(99)00010-5
5. Wong E. T., Ngoi S. M., Lee C. G. L., Improved co-expression of multiple genes in vectors containing internal ribosome entry sites (IRESes) from human genes. Gene Therapy 2002 9 5 337 344 2-s2.0-0036211863 10.1038/sj/gt/3301667
6. Kozak M., A second look at cellular mRNA sequences said to function as internal ribosome entry sites. Nucleic Acids Research 2005 33 20 6593 6602 2-s2.0-29144444289 10.1093/nar/gki958
7. Baranick B. T., Lemp N. A., Nagashima J., Hiraoka K., Kasahara N., Logg C. R., Splicing mediates the activity of four putative cellular internal ribosome entry sites. Proceedings of the National Academy of Sciences of the United States of America 2008 105 12 4733 4738 2-s2.0-42449126726 10.1073/pnas.0710650105
8. Ryan M. D., King A. M. Q., Thomas G. P., Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. Journal of General Virology 1991 72 11 2727 2732 2-s2.0-0025934319
9. Ryan M. D., Drew J., Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. EMBO Journal 1994 13 4 928 933 2-s2.0-0028058011
10. de Felipe P., Hughes L. E., Ryan M. D., Brown J. D., Co-translational, intraribosomal cleavage of polypeptides by the foot-and-mouth disease virus 2A peptide. The Journal of Biological Chemistry 2003 278 13 11441 11448 2-s2.0-0037501357 10.1074/jbc.M211644200
11. Ryan M. D., Donnelly M. L. L., Flint M., Sobrino F., Domingo E., Foot-and-mouth disease virus proteinases. Foot and Mouth Disease Current Perspectives 2004 London, UK Horizon Bioscience 53 76
12. Szymczak A. L., Workman C. J., Wang Y., Vignali K. M., Dilioglou S., Vanin E. F., Vignali D. A. A., Correction of multi-gene deficiency in vivo using a single "self-cleaving" 2A peptide-based retroviral vector. Nature Biotechnology 2004 22 589 594
13. Szymczak A. L., Vignali D. A. A., Development of 2A peptide-based strategies in the design of multicistronic vectors. Expert Opinion on Biological Therapy 2005 5 5 627 638 2-s2.0-20344377636 10.1517/14712598.5.5.627
14. Huang X., Wilber A. C., Bao L., Tuong D., Tolar J., Orchard P. J., Levine B. L., June C. H., McIvor R. S., Blazar B. R., Zhou X., Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system. Blood 2006 107 2 483 491 2-s2.0-30444432097 10.1182/blood-2005-05-2133
15. Hart D. P., Xue S. A., Thomas S., Cesco-Gaspere M., Tranter A., Willcox B., Lee S. P., Steven N., Morris E. C., Stauss H. J., Retroviral transfer of a dominant TCR prevents surface expression of a large proportion of the endogenous TCR repertoire in human T cells. Gene Therapy 2008 15 8 625 631 2-s2.0-43049170430 10.1038/sj.gt.3303078
16. Hsiao E. C., Yoshinaga Y., Nguyen T. D., Musone S. L., Kim J. E., Swinton P., Espineda I., Manalac C., DeJong P. J., Conklin B. R., Marking embryonic stem cells with a 2A self-cleaving peptide: a NKX2-5 emerald GFP BAC reporter. PLoS ONE 2008 3 7 2-s2.0-49749108546 10.1371/journal.pone.0002532 e2532
17. Sommer C. A., Stadtfeld M., Murphy G. J., Hochedlinger K., Kotton D. N., Mostoslavsky G., Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 2009 27 3 543 549 2-s2.0-65249149666 10.1634/stemcells.2008-1075
18. Unger C., Kärner E., Treschow A., Stellan B., Felldin U., Concha H., Wendel M., Hovatta O., Aints A., Ährlund-Richter L., Dilbera M. S., Lentiviral-mediated HoxB4 expression in human embryonic stem cells initiates early hematopoiesis in a dose-dependent manner but does not promote myeloid differentiation. Stem Cells 2008 26 10 2455 2466 2-s2.0-55049112376 10.1634/stemcells.2007-0876
19. Kärner E., Unger C., Cerny R., Ährlund-Richter L., Ganss B., Dilber M. S., Wendel M., Differentiation of human embryonic stem cells into osteogenic or hematopoietic lineages: a dose-dependent effect of osterix over-expression. Journal of Cellular Physiology 2009 218 2 323 333 2-s2.0-58149238098 10.1002/jcp.21605
20. Shao L. S., Feng W., Sun Y., Bai H., Liu J., Currie C., Kim J., Gama R., Wang Z., Qian Z., Liaw L., Wu W. S., Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame. Cell Research 2009 19 3 296 306 2-s2.0-61849086230 10.1038/cr.2009.20
21. Carey B. W., Markoulaki S., Hanna J., Saha K., Gao Q., Mitalipova M., Jaenisch R., Reprogramming of murine and human somatic cells using a single polycistronic vector. Proceedings of the National Academy of Sciences of the United States of America 2009 106 1 157 162 2-s2.0-58549096370 10.1073/pnas.0811426106
22. Kaji K., Norrby K., Paca A., Mileikovsky M., Mohseni P., Woltjen K., Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009 458 7239 771 775 2-s2.0-64749111225 10.1038/nature07864
23. Woltjen K., Michael I. P., Mohseni P., Desai R., Mileikovsky M., Hämäläinen R., Cowling R., Wang W., Liu P., Gertsenstein M., Kaji K., Sung H. K., Nagy A., PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009 458 7239 766 770 2-s2.0-64749083939 10.1038/nature07863
24. Yang S., Cohen C. J., Peng P. D., Zhao Y., Cassard L., Yu Z., Zheng Z., Jones S., Restifo N. P., Rosenberg S. A., Morgan R. A., Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition. Gene Therapy 2008 15 21 1411 1423 2-s2.0-54549106702 10.1038/gt.2008.90
25. Takata Y., Kishine H., Sone T., Andoh T., Nozaki M., Poderycki M., Chesnut J. D., Imamoto F., Generation of iPS cells using a BacMam expression system. Cell Structure and Function 2011 36 2 209 222
26. Furler S., Paterna J. C., Weibel M., Büeler H., Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons. Gene Therapy 2001 8 11 864 873 2-s2.0-0034973713 10.1038/sj.gt.3301469
27. Donnelly M. L. L., Hughes L. E., Luke G., Mendoza H., ten Dam E., Gani D., Ryan M. D., The "cleavage" activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring "2A-like" sequences. Journal of General Virology 2001 82 5 1027 1041 2-s2.0-0035005706
28. Fang J., Qian J. J., Yi S., Harding T. C., Tu G. H., VanRoey M., Jooss K., Stable antibody expression at therapeutic levels using the 2A peptide. Nature Biotechnology 2005 23 5 584 590 2-s2.0-22744444388 10.1038/nbt1087
29. Funston G. M., Kallioinen S. E., de Felipe P., Ryan M. D., Iggo R. D., Expression of heterologous genes in oncolytic adenoviruses using picornaviral 2A sequences that trigger ribosome skipping. Journal of General Virology 2008 89 2 389 396 2-s2.0-41649107151 10.1099/vir.0.83444-0
30. Trichas G., Begbie J., Srinivas S., Use of the viral 2A peptide for bicistronic expression in transgenic mice. BMC Biology 2008 6, article 40 2-s2.0-53149149440 10.1186/1741-7007-6-40
31. Tan Y., Liang H., Chen A., Guo X., Coexpression of double or triple copies of the rabies virus glycoprotein gene using a "self-cleaving" 2A peptide-based replication-defective human adenovirus serotype 5 vector. Biologicals 2010 38 5 586 593 2-s2.0-77956226595 10.1016/j.biologicals.2010.06. 001
32. Camper N., Byrne T., Burden R. E., Lowry J., Gray B., Johnston J. A., Migaud M. E., Olwill S. A., Buick R. J., Scott C. J., Stable expression and purification of a functional processed Fab' fragment from a single nascent polypeptide in CHO cells expressing the mCAT-1 retroviral receptor. Journal of Immunological Methods 2011 372 1-2 30 41 10.1016/j.jim.2011.06.029
33. de Felipe P., Luke G. A., Brown J. D., Ryan M. D., Inhibition of 2A-mediated "cleavage" of certain artificial polyproteins bearing N-terminal signal sequences. Biotechnology Journal 2010 5 2 213 223 2-s2.0-76649115600 10.1002/biot.200900134
34. Holst J., Szymczak-Workman A. L., Vignali K. M., Burton A. R., Workman C. J., Vignali D. A. A., Generation of T-cell receptor retrogenic mice. Nature Protocols 2006 1 1 406 417 2-s2.0-34250642773 10.1038/nprot.2006.61
35. Ryan M. D., Donnelly M. L. L., Lewis A., Mehrotra A. P., Wilkie J., Gani D., A model for nonstoichiometric, cotranslational protein scission in eukaryotic ribosomes. Bioorganic Chemistry 1999 27 1 55 79 2-s2.0-0032830440 10.1006/bioo.1998.1119
36. Donnelly M. L. L., Luke G., Mehrotra A., Li X., Hughes L. E., Gani D., Ryan M. D., Analysis of the aphthovirus 2A/2B polyprotein "cleavage" mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'. Journal of General Virology 2001 82 5 1013 1025 2-s2.0-0035015174
37. Ryan M. D., Luke G., Hughes L. E., Semler B., Wimmer E., The aphtho- and cardiovirus "primary" 2A/2B polyprotein 'cleavage'. Molecular Biology of Picornaviruses 2002 Washington, DC, USA ASM Press 213 223
38. Hardesty B., Kramer G., Folding of a nascent peptide on the ribosome. Progress in Nucleic Acid Research and Molecular Biology 2000 66 41 66 2-s2.0-0035193534
39. de Felipe P., Ryan M. D., Targeting of proteins derived from self-processing polyproteins containing multiple signal sequences. Traffic 2004 5 8 616 626 2-s2.0-4344649387 10.1111/j.1398-9219.2004.00205.x
40. Klump H., Schiedlmeier B., Vogt B., Ryan M., Ostertag W., Baum C., Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategy. Gene Therapy 2001 8 10 811 817 2-s2.0-0034990345 10.1038/sj.gt.3301447
41. Milsom M. D., Woolford L. B., Margison G. P., Humphries R. K., Fairbairn L. J., Enhanced in vivo selection of bone marrow cells by retroviral-mediated coexpression of mutant O6-methylguanine-DNA-methyltransferase and HOXB4. Molecular Therapy 2004 10 4 862 873 10.1016/j.ymthe.2004.07.019
42. Simmons A. D., Moskalenko M., Creson J., Fang J., Yi S., VanRoey M. J., Allison J. P., Jooss K., Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity. Cancer Immunology, Immunotherapy 2008 57 1263 1270 2-s2.0-44249090471 10.1007/s00262-008-0451-3
43. Lengler J., Holzmüller H., Salmons B., Günzburg W. H., Renner M., FMDV-2A sequence and protein arrangement contribute to functionality of CYP2B1-reporter fusion protein. Analytical Biochemistry 2005 343 1 116 124 2-s2.0-22144476888 10.1016/j.ab.2005.05.004
44. Sharma P., Yan F., Doronina V. A., Escuin-Ordinas H., Ryan M. D., Brown J., A peptides provide distinct solutions to driving stop-carry on translational recoding. Nucleic Acids Research 2012 40 7 3143 3151 10.1093/nar/gkr1176
45. de Felipe P., Martín V., Cortés M. L., Ryan M., Izquierdo M., Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy. Gene Therapy 1999 6 2 198 208 2-s2.0-0033030109 10.1038/sj.gt.3300811
46. Ma C., Mitra A., Expressing multiple genes in a single open reading frame with the 2A region of foot-and-mouth disease virus as a linker. Molecular Breeding 2002 9 3 191 199 2-s2.0-0036355509 10.1023/A:1019760127368
47. Holst J., Wang H., Eder K. D., Workman C. J., Boyd K. L., Baquet Z., Singh H., Forbes K., Chruscinski A., Smeyne R., van Oers N. S. C., Utz P. J., Vignali D. A. A., Scalable signaling mediated by T cell antigen receptor-CD3 ITAMs ensures effective negative selection and prevents autoimmunity. Nature Immunology 2008 9 6 658 666 2-s2.0-44049096285 10.1038/ni.1611
48. Provost E., Rhee J., Leach S. D., Viral 2A peptides allow expression of multiple proteins from a single ORF in transgenic Zebrafish embryos. Genesis 2007 45 10 625 629 2-s2.0-36048993980 10.1002/dvg.20338
49. Kim J. H., Lee S. R., Li L. H., Park H. J., Park J. H., Lee K. Y., Kim M. K., Shin B. A., Choi S. Y., High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS ONE 2011 6 4 2-s2.0-79955707349 10.1371/journal.pone.0018556 e18556
50. Yu K. K., Aguilar K., Tsai J., Galimidi R., Gnanapragasam P., Yang L., Baltimore D., Use of mutated self-cleaving 2A peptides as a molecular rheostat to direct simultaneous formation of membrane and secreted anti-HIV immunoglobulins. PLoS ONE 2012 7 11 e50438 10.1371/journal.pone.0050438